Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Nina Zdinjak

Clever Leaves Inks $7.8M Product Deal With Australian Medical Cannabis Company

Clever Leaves Holdings Inc. (NASDAQ:CLVR) has inked a four-year take or pay supply agreement with an Australian medicinal cannabis company, Australian Natural Therapeutics Group.

Under the agreement, Clever Leaves will supply CBD isolate and GMP certified THC crude oil from its operation in Colombia and THC dried flower from its GACP- certified operation in Portugal. In addition, ANTG has committed to purchasing a minimum of $7.8M worth of product, with the next shipment planned for March 2022.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.